InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Hollingsworth Jane H, Director. Officer active across 1 companies, notably Diffusion Pharmaceuticals Inc.. Cumulatively, 3 disclosures have been logged. Total volume traded: €33k. The latest transaction was filed on 13 May 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
183 shares
Common Stock
SEC:0001437749-22-014181:0·
€16,56032,786 shares@ €0.5051100.0% of flow
Common Stock
SEC:0001437749-21-012537·
Ideal exit: 7 Feb 2022 (T+270)
€16,56032,786 shares@ €0.505150.0% of flow
Common Stock
SEC:0001437749-21-012537:0·
Ideal exit: 7 Feb 2022 (T+270)
3 of 3 declarations
About Hollingsworth Jane H
Jane H. Hollingsworth is a Board Member at Diffusion Pharmaceuticals Inc. She brings expertise in biotechnology and product development. Her role on the board allows her to contribute to the strategy and governance of the company. Jane is recognized for her ability to integrate scientific innovations into business development.
